We are thrilled to announce our latest investment in Vantis, a digital health application offering digital therapeutics for cardiovascular indications. btov Partners co-led this EUR 3.8m financing round together with firstminute capital and renowned angels such as the founders of think-cell.
Having known the team behind Vantis – Till Jansen, Maximilian Roedel, Ulrich Klank, Dr. Kevin Wiesner, and Priv.-Doz. Dr. Felix Jansen – almost since inception of the company, we were able to observe the ongoing stellar execution and rapid operational developments from the side line. Thanks for letting us be part of your journey to tackle Germany’s biggest cause of death!
Congratulations to the team of Vantis and welcome to the btov Portfolio!